1. Clinical Relevance of Antibodies to Cardiolipin in Patients with Chronic Hepatitis C
   Takashi Himoto et al, 2012, Journal of Clinical Laboratory Analysis CrossRef
2. High prevalence of a variety of autoantibodies in a population of hepatitis C virus‐infected individuals
   Luz Marina Navarta et al, 2018, APMIS CrossRef
3. Extrahepatic Manifestations and Autoantibodies in Patients with Hepatitis C Virus Infection
   Takashi Himoto et al, 2012, Clinical and Developmental Immunology CrossRef
4. The ratio of insulin-like growth factor-I/insulin-like growth factor–binding protein-3 in sera of patients with hepatitis C virus–related chronic liver disease as a predictive marker of insulin resistance
   Takashi Himoto et al, 2013, Nutrition Research CrossRef
5. Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis
   Takashi Himoto et al, 2013, Autoimmunity Highlights CrossRef
6. Verification of B-lymphocyte activating factor’s involvement in the exacerbation of insulin resistance as well as an autoimmune response in patients with nonalcoholic steatohepatitis and patients with HCV-related chronic liver disease
   Takashi Himoto et al, 2017, Diabetology & Metabolic Syndrome CrossRef